$4.00 0.16 (+4.17%)
2/13/2012 10:06 AM

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

CAPS Rating: 2 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Featured Broker Partners


Advertisement